Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure

Journal of the American College of Cardiology

Volumn 35, Issue 1, 2000, Pages 45-50

  Kukin, Marrick L ^a   Mannino, Michael M ^a   Freudenberger, Ronald S ^a   Kalman, Jill ^a   Buchholz Varley, Cathleen ^a   Ocampo, Ofelia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; METOPROLOL TARTRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART INDEX; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; LONG-TERM CARE; MALE; METOPROLOL; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0033955186     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00504-5     Document Type: Article

References (17)

1. Packer M, Bristow MR, Cohn JN, et al., for the U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
2. CIBIS II Investigators. The cardiac insufficiency bisoprolol study II: a randomized trial. Lancet 1999;353:9-13.
3. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-7.
4. Kukin ML, Kalman J, Mannino MM, Buchholz C, Ocampo O. Beta blockade in congestive heart failure: persistent adverse hemodynamic effects during chronic therapy with subsequent doses. Heart 1997;78:444-9.
5. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The six-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-23.
6. Weber KT, Janicki JS, McElroy PA. Determination of aerobic capacity and the severity of chronic cardiac and circulatory failure. Circulation 1987;76 Suppl VI:VI40-5.
7. Packer M, Medina N, Yushak M. Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart cathetenzation in patients with chronic heart failure. Circulation 1985;71:761-6.
8. Waagstein F, Hjalmarson A, Varnauskas E, Wallen I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;37:1022-36.
9. Waagstein F, Bristow MR, Swedberg K, et al., for the MDC Trial Study Group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-6.
10. Gilbert EM, Anderson JL, Deitchman D, et al. Long term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindilol versus placebo. Am J Med 1990;88:223-9.
11. Krum H, Sackner-Bernstein JD, Goldsmith RL, et al. Double-blind, placebo controlled study of the long term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995;92:1499-1506.
12. Englemeier RS, O'Connell JB, Walsh R, Rad N, Scanlon PJ, Gunnar RM. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy. A double-blind, randomized, placebo-controlled trial. Circulation 1985;72:536-46.
13. Anderson B, Blomstrom-Lundqvist C, Hedner T, Waagstein F. Exercise hemodynamics and myocardial metabolism during long term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol 1991;18:1059-66.
14. Currie PJ, Kelly MJ, McKenzie A, et al. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. J Am Coll Cardiol 1984;3:203-9.
15. Metra M, Nardi M, Giubbini R, Dei Cas L. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994;24:1678-87.
16. Olsen SI, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Col Cardiol 1995;25:1225-31.
17. Packer M, Cohn JN, on behalf of the steering committee and membership of the Advisory Council to Improve Outcomes Nationwide in Heart Failure. Consensus recommendations for the management of heart failure. Am J Cardiol 1999;83 Suppl 2A:17A-22A.